Top

Supportive Care in Cancer

Published in:

01-05-2024 | Megestrol Acetate | Correspondence

A taste alteration-related scale assesses megestrol to improve chemotherapy-induced anorexia

Authors: Lihong Wang, Yaling Tan, Lan Yao, Daqiang He

Published in: Supportive Care in Cancer | Issue 5/2024

Abstract

Purpose

We evaluated the efficacy of megestrol in improving chemotherapy-related anorexia by analyzing the related scales of taste alteration.

Methods

We conducted the current study on a group of advanced patients with cancer with two or more chemotherapy cycles. The chemotherapy-induced taste alteration scale (CiTAs) scale helped assess the megestrol effects on basic taste perception, aversive taste changes, unpleasant symptoms, and associated concerns. Furthermore, the Short Nutritional Assessment Questionnaire scale (SNAQ) helped measure the impact of megestrol on malnutrition likelihood in patients experiencing chemotherapy-induced anorexia. The World Health Organization Quality of Life (WHOQOL)-BREF Scale was used to evaluate the quality of life of participants, producing scores related to physical health, psychological well-being, environmental factors, and social relationships.

Results

The CiTAs scale assessment indicated that administering megestrol significantly enhanced taste perception among advanced patients with cancer undergoing chemotherapy. Notably, the megestrol group patients showed significantly higher Short Nutritional Assessment Questionnaire (SNAQ) scores than the control group. The megestrol group patients also exhibited higher physiological (PHYS) scores than their control group counterparts. However, this distinction was not statistically significant. The study findings indicate that patients who received megestrol demonstrated significantly higher scores in psychological (PSYCH) and environmental(ENVIR) domains than the control group. Furthermore, megestrol administration was associated with significantly elevated SOCIL and ENVIR levels in patients.

Conclusion

The proficient efficacy evaluation of megestrol in enhancing appetite, mitigating malnutrition likelihood, and improving the quality of life of chemotherapy-induced anorexic patients can be achieved through taste-related scales.

Lindley C, McCune JS, Thomason TE, Lauder D, Sauls A, Adkins S, Sawyer WT (1999) Perception of chemotherapy side effects cancer versus nonpatients with cancer. Cancer Pract 7(2):59–65. https://doi.org/10.1046/j.1523-5394.1999.07205.xCrossRefPubMed

Bernhardson B-M, Tishelman C, Rutqvist LE (2008) Self-reported taste and smell changes during cancer chemotherapy. Support Care Cancer: Off J Multinl Assoc Support Care Cancer 16(3):275–283. https://doi.org/10.1007/s00520-007-0319-7CrossRef

Kot E, Kucharska K, Monteleone AM, Monteleone P (2020) Structural and functional brain correlates of altered taste processing in anorexia nervosa: a systematic review. Eur Eating Disord Rev: J Eating Disord Assoc 28(2):122–40. https://doi.org/10.1002/erv.2713CrossRef

Kano T, Kanda K (2013) Development and validation of a chemotherapy-induced taste alteration scale. Oncol Nurs Forum 40(2):E79-85. https://doi.org/10.1188/13.ONF.E79-E85CrossRefPubMed

Pedersini R, Zamparini M, Bosio S, di Mauro P, Turla A, Monteverdi S, Zanini A et al (2022) Taste alterations during neo/adjuvant chemotherapy and subsequent follow-up in breast patients with cancer: a prospective single-center clinical study. Support Care Cancer: Off J Multinat Assoc Support Care Cancer 30(8):6955–61. https://doi.org/10.1007/s00520-022-07091-6CrossRef

Kruizenga HM, Seidell JC, de Vet HCW, Wierdsma NJ, van Bokhorst-de van der Schueren MAE (2005) Development and validation of a hospital screening tool for malnutrition: the Short Nutritional Assessment Questionnaire (SNAQ). Clin Nutri (Edinburgh, Scotland) 24(1):75–82. https://doi.org/10.1016/j.clnu.2004.07.015CrossRef

Wang T, Shen J (2018) Usefulness of Simplified Nutritional Appetite Questionnaire (SNAQ) in appetite assessment in elder patients with liver cirrhosis. J Nutr Health Aging 22(8):911–915. https://doi.org/10.1007/s12603-018-1086-5CrossRefPubMed

Harada K, Ochi K, Taguchi T, Nakamura T, Kanazawa M, Yoshida N, Neriya H et al (2017) Validity of the short nutritional assessment questionnaire for Japanese patients with cancer undergoing outpatient chemotherapy. J Med Investig: JMI 64(12):117–21CrossRef

Skevington SM, Lotfy M, O’Connell KA (2004) The World Health Organization’s WHOQOL-BREF quality of life assessment: psychometric properties and results of the international field trial A report from the WHOQOL Group. Qual Life Res: An Int J Qual Life Aspects Treat Care Rehabil 13(2):299–310. https://doi.org/10.1023/B:QURE.0000018486.91360.00CrossRef

10.

Jacobs JM, Ream ME, Pensak N, Nisotel LE, Fishbein JN, MacDonald JJ, Buzaglo J et al (2019) Patient experiences with oral chemotherapy: adherence, symptoms, and quality of life. J Natl Compr Cancer Network: JNCCN 17(3):221–28. https://doi.org/10.6004/jnccn.2018.7098CrossRef

11.

Liang LY, Teoh SE, Leon CY, Yaow DJ, Lin YM, Han MX, Yeo WS, Ng QX (2022) A systematic review and meta-analysis of the clinical use of megestrol acetate for cancer-related anorexia/cachexia. J Clin Med 11(13):3756. https://doi.org/10.3390/jcm11133756CrossRef

12.

Ma Y, Zhao W, Deng W, Wei C, Bie L, Zhang C, Li N, Luo S (2022) Megestrol acetate dispersible tablets with a 5-HT3 receptor antagonist and dexamethasone vs. 5-HT3 receptor antagonist plus dexamethasone, can better control chemotherapy-induced nausea and vomiting: a randomized controlled study. Ann Transl Med 10(20):1124. https://doi.org/10.21037/atm-22-4809CrossRefPubMedPubMedCentral

13.

Currow DC, Glare P, Louw S, Martin P, Clark K, Fazekas B, Agar MR (2021) A randomised, double blind, placebo-controlled trial of megestrol acetate or dexamethasone in treating symptomatic anorexia in people with advanced cancer. Scientific Reports 11(1):2421. https://doi.org/10.1038/s41598-021-82120-8CrossRefPubMedPubMedCentral

14.

Zheng Z, Chen J, He D, Xu Y, Chen L, Zhang T (2019) The effects of megestrol acetate on nutrition, inflammation and quality of life in elderly haemodialysis patients. Int Urol Nephrol. 51(9):1631–1638. https://doi.org/10.1007/s11255-019-02245-8CrossRefPubMed

15.

The CiTAS scale for evaluating taste alteration induced by chemotherapy: state of the art on its clinical use - PubMed’. Accessed 13 June 2023. https://pubmed.ncbi.nlm.nih.gov/31292411/.

16.

Anusiewicz CV, Li P, Patrician PA (2021) Measuring workplace bullying in a U.S. nursing population with the Short Negative Acts Questionnaire. Res Nurs Health 44(2):319–328. https://doi.org/10.1002/nur.22117CrossRefPubMedPubMedCentral

17.

Simon SR, Pilz W, Hoebers FJP, Leeters IPM, Schols AMWJ, Willemsen ACH, Winkens B, Baijens LWJ (2021) Malnutrition screening in head and neck patients with cancer with oropharyngeal dysphagia. Clin Nutr ESPEN 44:348–55. https://doi.org/10.1016/j.clnesp.2021.05.019CrossRefPubMed

18.

The Simplified Nutritional Appetite Questionnaire (SNAQ) as a screening tool for risk of malnutrition: optimal cutoff, factor structure, and validation in healthy community-dwelling older adults - PubMed’. Accessed 13 June 2023. https://pubmed.ncbi.nlm.nih.gov/32967354/.

19.

‘Acupuncture for quality of life in gastric patients with cancer undergoing adjuvant chemotherapy - PubMed’. Accessed 13 June 2023. https://pubmed.ncbi.nlm.nih.gov/34563627/.

20.

Ea, Dijkstra, Hospers Gap, Kranenbarg Em, Fleer J, Roodvoets Agh, Bahadoer Rr, Guren Mg, et al (2022) ‘Quality of life and late toxicity after short-course radiotherapy followed by chemotherapy or chemoradiotherapy for locally advanced rectal cancer - the RAPIDO trial’. Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology 171. https://doi.org/10.1016/j.radonc.2022.04.013.

21.

Zheng Z, Chen J, He D, Yuankai Xu, Chen L, Zhang T (2019) The effects of megestrol acetate on nutrition, inflammation and quality of life in elderly haemodialysis patients. Int Urol Nephrol 51(9):1631–1638. https://doi.org/10.1007/s11255-019-02245-8CrossRefPubMed

Title: A taste alteration-related scale assesses megestrol to improve chemotherapy-induced anorexia
Authors: Lihong Wang
Yaling Tan
Lan Yao
Daqiang He
Publication date: 01-05-2024
Publisher: Springer Berlin Heidelberg
Keywords: Megestrol Acetate
Cytostatic Therapy
Malnutrition
Published in: Supportive Care in Cancer / Issue 5/2024
Print ISSN: 0941-4355
Electronic ISSN: 1433-7339
DOI: https://doi.org/10.1007/s00520-024-08499-y

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Purpose

Methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 5/2024

Assessing the needs of patients with breast cancer and their families across various treatment phases using a Latent Dirichlet Allocation model: a text-mining approach to online health communities

Financial difficulties experienced by patients with gastrointestinal stromal tumours (GIST) in the Netherlands: data from a cross-sectional multicentre study

Attributes for a discrete-choice experiment on preferences of patients for oncology pharmacy consultations

Reply to: “Psychosocial symptoms associated with spiritual well‑being in Latino patients and caregivers coping with advanced cancer”

Antineoplastic therapy is an independent risk factor for dental caries in childhood cancer patients: a retrospective cohort study

Preventive and restorative alternatives to caries by irradiation: a scoping review

Keynote webinar | Spotlight on antibody–drug conjugates in cancer